Plunkett Research Online: Akesis Pharmaceuticals Inc

AKESIS PHARMACEUTICALS INC (AKESQ) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Akesis Delaware is in an early stage biopharmaceutical company engaged in the discovery, development and commercialization of complementary and alternative therapies for the treatment of three principal forms of carbohydrate intolerance - Type 2 diabetes, Syndrome X, and impaired glucose tolerance, .....


AKESIS PHARMACEUTICALS INC

Ticker: AKESQ
Exchange: PINX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 858 454-4311
Fax: 858 348-2183
Address: 888 Prospect Street
La Jolla, CA 92037 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Akesis Delaware is in an early stage biopharmaceutical company engaged in the discovery, development and commercialization of complementary and alternative therapies for the treatment of three principal forms of carbohydrate intolerance - Type 2 diabetes, Syndrome X, and impaired glucose tolerance, .....See More See More

$USD, In whole numbers 2016201520142013201220112010
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture